C3AR1 and pancreatic neoplasm: We determined the effect of inhibiting C3aR with the small-molecule antagonist SB290157 in a syngeneic mouse model of pancreatic cancer and its enhancement of NK cell infiltration in the TME and on tumor growth delay.